# A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region

> **NCT07065344** · — · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 500 (estimated)

## Conditions studied

- Hematology
- Diffused Large B Cell Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07065344
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-31
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07065344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07065344, "A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07065344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*